Early introduction of insulin therapy can attain and maintain glucose targets when oral antidiabetic drug (OAD) regimens have failed to achieve glycemic goals, thereby reducing the risk of diabetes-related complications [11]. The gene discussed is INS; the disease is diabetes mellitus.